European Commission Approves Navidea's Sentinel Lymph Node Detection Agent Lymphoseek

By: via Benzinga
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) has announced that the European Commission has granted marketing authorization for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.